- Q4 2023 GlycoMimetics Inc Earnings Call TranscriptMar 27, 2024€2.85 (+11.33%)Earnings
- Q3 2023 GlycoMimetics Inc Earnings Call TranscriptNov 03, 2023€1.2 (+0.67%)Earnings
- Q2 2023 GlycoMimetics Inc Earnings Call TranscriptAug 02, 2023€1.48Earnings
- GlycoMimetics Inc at Jefferies Healthcare Conference TranscriptJun 07, 2023
- Q1 2023 GlycoMimetics Inc Earnings Call TranscriptMay 03, 2023€1.25 (-3.25%)Earnings
- Q4 2022 GlycoMimetics Inc Earnings Call TranscriptMar 29, 2023€1.28 (-0.19%)Earnings
- Q3 2022 GlycoMimetics Inc Earnings Call TranscriptNov 09, 2022€0.6596 (-1.11%)Earnings
- Q2 2022 GlycoMimetics Inc Earnings Call TranscriptAug 03, 2022€0.6544 (+2.15%)Earnings
- Q1 2022 GlycoMimetics Inc Earnings Call TranscriptApr 28, 2022€0.7966 (-3.28%)Earnings
- Q4 2021 GlycoMimetics Inc Earnings Call TranscriptMar 03, 2022€1.07 (-9.32%)Earnings
- Q3 2021 GlycoMimetics Inc Earnings Call TranscriptNov 02, 2021€1.75 (+3.55%)Earnings
- Q2 2021 GlycoMimetics Inc Earnings Call TranscriptAug 05, 2021€1.65 (-2.37%)Earnings
- GlycoMimetics Inc Annual Shareholders Meeting TranscriptMay 18, 2021
- Q1 2021 GlycoMimetics Inc Earnings Call TranscriptMay 03, 2021€1.97 (-7.08%)Earnings
- Q4 2020 GlycoMimetics Inc Earnings Call TranscriptMar 02, 2021€2.92 (+4.29%)Earnings
- GlycoMimetics Inc at Jefferies Virtual London Healthcare Conference TranscriptNov 19, 2020
- GlycoMimetics Inc at Stifel Virtual Healthcare Conference TranscriptNov 17, 2020
- Q3 2020 GlycoMimetics Inc Earnings Call TranscriptNov 06, 2020€2.54 (+1.60%)Earnings
- Q2 2020 GlycoMimetics Inc Earnings Call TranscriptJul 31, 2020€3.5 (-0.57%)Earnings
- GlycoMimetics Inc Annual Shareholders Meeting TranscriptMay 22, 2020
- Q1 2020 GlycoMimetics Inc Earnings Call TranscriptMay 01, 2020€2.48Earnings
- Q4 2019 GlycoMimetics Inc Earnings Call TranscriptFeb 28, 2020€3.36 (+2.44%)Earnings
- Q3 2019 GlycoMimetics Inc Earnings Call TranscriptNov 07, 2019€5.05 (-2.88%)Earnings
- GlycoMimetics Inc at Morgan Stanley Healthcare Conference TranscriptSep 11, 2019
- Q2 2019 GlycoMimetics Inc Earnings Call TranscriptAug 01, 2019€8.19 (+0.86%)Earnings
- Q1 2019 GlycoMimetics Inc Earnings Call TranscriptMay 02, 2019€10.35 (-5.82%)Earnings
- Q4 2018 GlycoMimetics Inc Earnings Call TranscriptMar 06, 2019€10.17 (-2.21%)Earnings
GlycoMimetics Inc at Jefferies Healthcare Conference Transcript
Welcome, everyone. And our next presenting company is GlycoMimetics. And I welcome CEO, Harout Semerjian. How are you?
I'm very good. Thank you.
Questions & Answers
Awesome. Yeah. Maybe before we talk about your exciting program and the upcoming catalysts, just for the people who maybe already know GlycoMimetics, but maybe some of them are new to the story, what's your updated elevator pitch for investors?
Thank you, Roger. GlycoMimetics is a clinical-stage company, actually a late-clinical stage company at this point, really focusing on debilitating diseases such as oncology, hematology, inflammatory diseases. We have a proprietary platform dealing with carbohydrates and glycobiology, which we believe is a very exciting area. And now more and more, we're starting to bring some of
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)